| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 136, 4880-4886, Copyright © 1995 by Endocrine Society
ARTICLES |
MM Zdanowicz, J Moyse, MA Wingertzahn, M O'Connor, S Teichberg and AE Slonim
Department of Pediatrics, North Shore University Hospital-Cornell University Medical College, Manhasset, New York 11030, USA.
In muscular dystrophy there is an imbalance between muscle protein synthesis and protein degradation, resulting in net muscle catabolism and progressive muscle weakness and wasting. Both insulin and insulin- like growth factor I (IGF-I) are known to have an anabolic effect on skeletal muscle, which is believed to be enhanced in the presence of elevated concentrations of amino acids. We examined the effects of 4- week administration of recombinant human IGF-I (rhIGF-I), both alone and supplemented with a high protein diet (HPD), on muscle metabolism, morphology, and function in the 129 ReJ dystrophic mouse. rhIGF-I significantly reduced muscle protein degradation (P < 0.001), increased muscle protein content (P < 0.05), decreased fiber area variability (P < 0.01), and increased hind limb utilization (P < 0.01). Supplementation of rhIGF-I therapy with a HPD resulted in a significant increase in muscle protein synthesis (P < 0.05) in addition to a further increase in the above parameters. We conclude that rhIGF-I causes an improvement in muscle metabolism, morphology, and function in dystrophic mice, and this effect is further enhanced by the presence of a HPD.
This article has been cited by other articles:
 |
|
 |
|
  V. Jacquemin, G. S. Butler-Browne, D. Furling, and V. Mouly IL-13 mediates the recruitment of reserve cells for fusion during IGF-1-induced hypertrophy of human myotubes J. Cell Sci., February 15, 2007; 120(4): 670 - 681. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kamei, S. Miura, M. Suzuki, Y. Kai, J. Mizukami, T. Taniguchi, K. Mochida, T. Hata, J. Matsuda, H. Aburatani, et al. Skeletal Muscle FOXO1 (FKHR) Transgenic Mice Have Less Skeletal Muscle Mass, Down-regulated Type I (Slow Twitch/Red Muscle) Fiber Genes, and Impaired Glycemic Control J. Biol. Chem., September 24, 2004; 279(39): 41114 - 41123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Zdanowicz and S. Teichberg Effects of Insulin-Like Growth Factor-1/Binding Protein-3 Complex on Muscle Atrophy in Rats Experimental Biology and Medicine, September 1, 2003; 228(8): 891 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Gregorevic, D. R. Plant, K. S. Leeding, L. A. Bach, and G. S. Lynch Improved Contractile Function of the mdx Dystrophic Mouse Diaphragm Muscle after Insulin-Like Growth Factor-I Administration Am. J. Pathol., December 1, 2002; 161(6): 2263 - 2272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Huard, Y. Li, and F. H. Fu Muscle Injuries and Repair: Current Trends in Research J. Bone Joint Surg. Am., May 1, 2002; 84(5): 822 - 832. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fukushima, N. Badlani, A. Usas, F. Riano, F. H. Fu, and J. Huard The Use of an Antifibrosis Agent to Improve Muscle Recovery after Laceration Am. J. Sports Med., July 1, 2001; 29(4): 394 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Furling, A. Marette, and J. Puymirat Insulin-Like Growth Factor I Circumvents Defective Insulin Action in Human Myotonic Dystrophy Skeletal Muscle Cells Endocrinology, September 1, 1999; 140(9): 4244 - 4250. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. R. Barton-Davis, D. I. Shoturma, A. Musaro, N. Rosenthal, and H. L. Sweeney Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function PNAS, December 22, 1998; 95(26): 15603 - 15607. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
